A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication

NCT01868061 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1068

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Lebrikizumab
DRUG: Placebo

Sponsor

Hoffmann-La Roche